Chandra Bhagat Pharma Share Price | Chandra Bhagat Pharma Stock Screener
CBPL
Pharmaceuticals
Track Chandra Bhagat Pharma share price live with TickJournal's free stock screener.
Check CBPL annual price range for the annual price range and momentum.
Use the Chandra Bhagat Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Chandra Bhagat Pharma Market Cap
₹24.90 Cr.
CBPL P/E Ratio (TTM)
-
Chandra Bhagat Pharma P/B Ratio
0.83
EPS (TTM)
₹1.14
Dividend Yield
-
Debt to Equity
0.63
CBPL 52 Week High
-
Chandra Bhagat Pharma 52 Week Low
-
Operating Margin
-
Profit Margin
-
CBPL Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹102.00
Total Equity
₹30.00
Chandra Bhagat Pharma Share Price Chart
Screen Chandra Bhagat Pharma share price with an interactive chart. Analyse CBPL price trends and volatility across different timeframes.
Chandra Bhagat Pharma Company Profile - Fundamental Screener
Screen Chandra Bhagat Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CBPL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE07QQ01016
Chandra Bhagat Pharma Balance Sheet Screener
Screen CBPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 102 | 102 | 61 | 73 | 72 | 75 | 83 |
| Current Assets | 98 | 98 | 58 | 71 | 70 | 73 | 81 |
| Fixed Assets | 3 | 3 | 1 | 1 | 0 | 0 | 1 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 2 | 2 | 6 | 8 | 13 | 15 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 30 | 29 | 28 | 27 | 26 | 26 | 14 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 1 |
| Reserves & Surplus | 22 | 22 | 20 | 19 | 18 | 18 | 14 |
Chandra Bhagat Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Chandra Bhagat Pharma income statement and profit fundamentals.
Analyze CBPL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Chandra Bhagat Pharma share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 92 | 233 | 120 | 96 | 71 | 94 | 107 |
| Expenses | 0 | 88 | 228 | 116 | 91 | 67 | 91 | 102 |
| EBITDA | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Operating Profit % | 0.00% | -2.00% | -3.00% | 3.00% | 3.00% | 5.00% | 3.00% | 4.00% |
| Depreciation | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 2 | 1 | 2 | 3 | 4 | 3 | 4 |
| Profit Before Tax | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 |
| Tax | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 |
| EPS | 0.00 | 1.14 | 2.03 | 1.20 | 1.06 | 0.25 | 0.55 | 13.38 |
Chandra Bhagat Pharma Cash Flow Screener - Liquidity Fundamentals
Screen CBPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -6 | 6 | 5 | 12 | 8 | -7 | 4 | -6 | -9 | 0 |
| Investing Activities | -1 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 2 | -6 | -4 | -10 | -6 | 7 | -4 | 7 | 8 | 0 |
| Net Cash Flow | -5 | -2 | 1 | 3 | 2 | 0 | 0 | 0 | -1 | 0 |
Chandra Bhagat Pharma Shareholding Pattern Screener
See Chandra Bhagat Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Chandra Bhagat Pharma promoter holding and ownership changes for CBPL on TickJournal.
| Item | 2026-Mar | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Sept | 2023-Mar | 2022-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.02% | 72.19% | 71.20% | 69.29% | 68.77% | 68.69% | 68.24% | 69.09% |
| FII Holding | 0.00% | 0.61% | 0.61% | 0.48% | 1.33% | 1.33% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.89% | 0.89% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.33% | 11.84% | 11.16% | 12.84% | 16.92% | 17.07% | 18.98% | 18.97% |
| Other Holding | 15.65% | 15.36% | 17.03% | 17.39% | 12.09% | 12.02% | 12.78% | 11.94% |
| Shareholder Count | 280 | 301 | 316 | 315 | 152 | 134 | 146 | 126 |
Chandra Bhagat Pharma Share Dividend Screener - Share Yield Analysis
Check Chandra Bhagat Pharma dividend history with payout and yield data.
View Chandra Bhagat Pharma dividend details including ex-dates and amounts for CBPL stock.
Chandra Bhagat Pharma Stock Index Membership
See which indices include Chandra Bhagat Pharma stock.
Check CBPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Chandra Bhagat Pharma Market Events Screener - Corporate Actions
Get Chandra Bhagat Pharma corporate actions including splits, bonuses, and buybacks.
Check Chandra Bhagat Pharma stock events that may affect CBPL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.31% | ||
| Annual General Meeting | NA | -2.27% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 2.11% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 2.13% |
Chandra Bhagat Pharma Competitors Screener - Peer Comparison
Screen CBPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Chandra Bhagat Pharma Company Announcements - News Screener
Screen CBPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-21 | Certificate For NON-Applicability Of Corporate Governance As On 31 March 2026. | - |
| 2026-04-01 | Disclosure Under Regulation 30. | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-01-21 | Non Applicability Of Corporate Governance Report Certificate. | - |
| 2025-11-13 | Un-Audited Result For Half Year Ended September 30 2025. | - |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th November 2025 For Approval Of Un-Audited Result As On 30.09.2025 | - |
| 2025-11-07 | Board Meeting Intimation for For Approval Of Un-Audited Result For The Half Year Ended 30Th September 2025 | - |
| 2025-10-20 | Disclosure | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-30 | Closure of Trading Window | - |
| 2025-09-06 | Reg. 34 (1) Annual Report. | - |
| 2025-09-06 | Notice Of Shareholders Meeting Held On September 30 2025. | - |
| 2025-09-06 | Board Meeting Outcome for Outcome Of The Board Meeting Held On September 062025. | - |
| 2025-05-29 | Appointment Of Secretarial Auditor. | - |
| 2025-05-29 | Result For The Financial Year March 31 2025. | - |
| 2025-05-29 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2025-05-24 | Board Meeting Intimation for Approval Of Audited Financial Statement As On March 31 2025. | - |
| 2025-04-21 | General-Updates | - |
| 2025-03-31 | Closure of Trading Window | - |